Immunotherapy in head and neck squamous cell carcinoma: a narrative review

por Sharon, Shay, Bell, R. Bryan
Publicado 2022

Implantable biomaterials to provide local immunotherapy following surgical resection

por Gough, Michael J., Baird, Jason R., Bell, R. Bryan
Publicado 2018

Moving beyond the T cell synapse for combination neoadjuvant immunotherapy in head and neck cancer

por Bell, R. Bryan, Gough, Michael, Crittenden, Marka, Young, Kristina
Publicado 2022

Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance

por Couey, Marcus A., Bell, R. Bryan, Patel, Ashish A., Romba, Meghan C., Crittenden, Marka R., Curti, Brendan D., Urba, Walter J., Leidner, Rom S.
Publicado 2019

OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancer

por Montler, Ryan, Bell, R Bryan, Thalhofer, Colin, Leidner, Rom, Feng, Zipei, Fox, Bernard A, Cheng, Allen C, Bui, Tuan G, Tucker, Christopher, Hoen, Helena, Weinberg, Andrew
Publicado 2016

A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection

por Sharon, Shay, Baird, Jason R., Bambina, Shelly, Kramer, Gwen, Blair, Tiffany C., Jensen, Shawn M., Leidner, Rom S., Bell, R. Bryan, Casap, Nardy, Crittenden, Marka R., Gough, Michael J.
Publicado 2021

Assessment of the tumor immune-environment in patients with head and neck cancer

por Feng, Zipei, Bethmann, Daniel, Kappler, Matthias, Ballesteros-Merino, Carmen, Eckert, Alexander, Bell, R Bryan, Cheng, Allen, Bui, Tuan, Leidner, Rom, Bifulco, Carlo, Wickenhauser, Claudia, Fox, Bernard A, Seliger, Barbara
Publicado 2015

Characterizing the immunoprofile and endogenous immune response to squamous cell carcinomas of the head and neck to guide development of effective immunotherapy strategies

por Moudgil, Tarsem, Bell, R Bryan, Leidner, Rom, Feng, Zipei, Paustian, Christopher, Dubay, Christopher, Hilton, Traci L, Curti, Brendan, Urba, Walter J, Bifulco, Carlo B, Hu, Hong-Ming, Fox, Bernard A
Publicado 2014

Novel strategy to monitor apparent tumor-specific T cells in patients with cancer

por van de Ven, Rieneke, Hilton, Traci L, Dubay, Christopher J, Puri, Sachin, Hu, Hong-Ming, Leidner, Rom S, Bell, R Bryan, Urba, Walter J, Curti, Brendan D, Aung, Sandra, Fox, Bernard A
Publicado 2013

STING expression and response to treatment with STING ligands in premalignant and malignant disease

por Baird, Jason R., Feng, Zipeng, Xiao, Hong D., Friedman, David, Cottam, Ben, Fox, Bernard A., Kramer, Gwen, Leidner, Rom S., Bell, R. Bryan, Young, Kristina H., Crittenden, Marka R., Gough, Michael J.
Publicado 2017

Correction: STING expression and response to treatment with STING ligands in premalignant and malignant disease

por Baird, Jason R., Feng, Zipei, Xiao, Hong D., Friedman, David, Cottam, Ben, Fox, Bernard A., Kramer, Gwen, Leidner, Rom S., Bell, R. Bryan, Young, Kristina H., Crittenden, Marka R., Gough, Michael J.
Publicado 2018

FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies

por Knorr, David, Leidner, Rom, Jensen, Shawn, Meng, Ryan, Jones, Andrew, Ballesteros-Merino, Carmen, Bell, R. Bryan, Baez, Maria, Sprott, David, Bifulco, Carlo, Piening, Brian, Dahan, Rony, Fox, Bernard A., Ravetch, Jeffrey
Publicado 2023

Developing an immunotherapy strategy for the effective treatment of patients with squamous cell carcinoma of the head and neck

por Moudgil, Tarsem, Bell, R Bryan, Leidner, Rom, Van de Ven, Rieneke, Feng, Zipei, Affentoulis, Michael, Paustian, Christopher, Dubay, Christopher, Hilton, Traci L, Urba, Walter J, Hu, Hong-Ming, Bifulco, Carlo B, Fox, Bernard A
Publicado 2013

Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carci...

por Leidner, Rom, Crittenden, Marka, Young, Kristina, Xiao, Hong, Wu, Yaping, Couey, Marcus A, Patel, Ashish A, Cheng, Allen C, Watters, Amber L, Bifulco, Carlo, Morris, George, Rushforth, Lessli, Nemeth, Shorin, Urba, Walter J, Gough, Michael, Bell, R Bryan
Publicado 2021

Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells

por Duhen, Rebekka, Ballesteros-Merino, Carmen, Frye, Alexandra K., Tran, Eric, Rajamanickam, Venkatesh, Chang, Shu-Ching, Koguchi, Yoshinobu, Bifulco, Carlo B., Bernard, Brady, Leidner, Rom S., Curti, Brendan D., Fox, Bernard A., Urba, Walter J., Bell, R. Bryan, Weinberg, Andrew D.
Publicado 2021

Adoptive TIL in HPV-negative oral scca

por Leidner, Rom, Curti, Brendan D, Payne, Roxanne M, Urba, Walter, Bahjat, Keith S, Koguchi, Yoshinobu, Nelson, Krista, Moore, Jennifer A, Crittenden, Marka, Ying, Yedeh, Patel, Ashish, Cheng, Allen, Bui, Tuan G, Hilton, Traci, Paustian, Christopher, Puri, Sachin, Hu, Hong Ming, Bifulco, Carlo, Feng, Zipei, Bell, R Bryan, Fox, Bernard
Publicado 2015

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

por Cohen, Ezra E. W., Bell, R. Bryan, Bifulco, Carlo B., Burtness, Barbara, Gillison, Maura L., Harrington, Kevin J., Le, Quynh-Thu, Lee, Nancy Y., Leidner, Rom, Lewis, Rebecca L., Licitra, Lisa, Mehanna, Hisham, Mell, Loren K., Raben, Adam, Sikora, Andrew G., Uppaluri, Ravindra, Whitworth, Fernanda, Zandberg, Dan P., Ferris, Robert L.
Publicado 2019